Clinical genomic profiling to identify actionable alterations for very early relapsed triple-negative breast cancer patients in the Chinese population

BACKGROUND: Triple-negative breast cancer (TNBC) represents about 19% of all breast cancer cases in the Chinese population. Lack of targeted therapy contributes to the poorer outcomes compared with other breast cancer subtypes. Comprehensive genomic profiling helps to explore the clinically relevant...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Liye, Zhai, Qinglian, Lu, Qianyi, Lee, Kaping, Zheng, Qiufan, Hong, Ruoxi, Wang, Shusen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Medical Genetics & Genomics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381897/
https://www.ncbi.nlm.nih.gov/pubmed/34396843
http://dx.doi.org/10.1080/07853890.2021.1966086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381897/
https://www.ncbi.nlm.nih.gov/pubmed/34396843
http://dx.doi.org/10.1080/07853890.2021.1966086

Ejemplares similares